Renee D. Gala

CIK: 0001607737

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)2 (9.5%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)10 (47.6%)

Compensation grants

Other (G, F, J, C, D, …)9 (42.9%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

JAZZ

Jazz Pharmaceuticals plc

DirectorOfficer

DXCM

DEXCOM INC

Director

Discretionary Trading P&L

Holdings

Transaction History (21 total)

JAZZ
Jazz Pharmaceuticals plc
Oct 6, 2026
Sale(S)
Direct
2K shares at avg. $236.40$473K
JAZZ
Jazz Pharmaceuticals plc
Sep 8, 2026
Sale(S)
Direct
2K shares at avg. $243.03$486K
JAZZ
Jazz Pharmaceuticals plc
Sep 8, 2026
Tax Payment(F)
Direct
2K shares at avg. $246.81$485K
JAZZ
Jazz Pharmaceuticals plc
Jun 30, 2026
Tax Payment(F)
Direct
4.8K shares at avg. $237.72$1.1M
JAZZ
Jazz Pharmaceuticals plc
Jun 3, 2026
Gift(G)
Direct
600 shares-
DXCM
DEXCOM INC
May 28, 2026
Award(A)
Direct
5.6K shares-
JAZZ
Jazz Pharmaceuticals plc
Mar 5, 2026
Tax Payment(F)
Direct
7.1K shares at avg. $188.69$1.3M
JAZZ
Jazz Pharmaceuticals plc
Feb 26, 2026
Award(A)
Direct
44.5K shares-
JAZZ
Jazz Pharmaceuticals plc
Jan 16, 2026
Award(A)
Direct
12.7K shares-
JAZZ
Jazz Pharmaceuticals plc
Jan 16, 2026
Tax Payment(F)
Direct
5.4K shares at avg. $171.16$919K
JAZZ
Jazz Pharmaceuticals plc
Dec 5, 2025
Tax Payment(F)
Direct
80 shares at avg. $166.91$13K
JAZZ
Jazz Pharmaceuticals plc
Aug 7, 2025
Award(A)
Direct
18.8K shares-
DXCM
DEXCOM INC
May 8, 2025
Award(A)
Direct
1.2K shares-
DXCM
DEXCOM INC
May 8, 2025
Award(A)
Direct
5.1K shares-
DXCM
DEXCOM INC
Mar 6, 2025
Award(A)
Direct
5.7K shares-
JAZZ
Jazz Pharmaceuticals plc
Mar 5, 2025
Disposition(D)
Direct
5.7K shares at avg. $138.95$793K
JAZZ
Jazz Pharmaceuticals plc
Feb 27, 2025
Award(A)
Direct
11.6K shares-
JAZZ
Jazz Pharmaceuticals plc
Feb 27, 2025
Award(A)
Direct
23.1K shares-
JAZZ
Jazz Pharmaceuticals plc
Jan 17, 2025
Tax Payment(F)
Direct
3.3K shares at avg. $122.62$405K
JAZZ
Jazz Pharmaceuticals plc
Jan 17, 2025
Award(A)
Direct
7.7K shares-
JAZZ
Jazz Pharmaceuticals plc
Dec 5, 2024
Tax Payment(F)
Direct
80 shares at avg. $123.45$10K

		Type	Shares	Price		Ownership
Oct 6, 2026	JAZZ Jazz Pharmaceuticals plc	Sale(S)	2,000	$236.40	$472,800	Direct
Sep 8, 2026	JAZZ Jazz Pharmaceuticals plc	Sale(S)	2,000	$243.03	$486,060	Direct
Sep 8, 2026	JAZZ Jazz Pharmaceuticals plc	Tax Payment(F)	1,967	$246.81	$485,475	Direct
Jun 30, 2026	JAZZ Jazz Pharmaceuticals plc	Tax Payment(F)	4,835	$237.72	$1,149,376	Direct
Jun 3, 2026	JAZZ Jazz Pharmaceuticals plc	Gift(G)	600	-	$0	Direct
May 28, 2026	DXCM DEXCOM INC	Award(A)	5,605	-	$0	Direct
Mar 5, 2026	JAZZ Jazz Pharmaceuticals plc	Tax Payment(F)	7,065	$188.69	$1,333,095	Direct
Feb 26, 2026	JAZZ Jazz Pharmaceuticals plc	Award(A)	44,465	-	$0	Direct
Jan 16, 2026	JAZZ Jazz Pharmaceuticals plc	Award(A)	12,741	-	$0	Direct
Jan 16, 2026	JAZZ Jazz Pharmaceuticals plc	Tax Payment(F)	5,371	$171.16	$919,300	Direct
Dec 5, 2025	JAZZ Jazz Pharmaceuticals plc	Tax Payment(F)	80	$166.91	$13,353	Direct
Aug 7, 2025	JAZZ Jazz Pharmaceuticals plc	Award(A)	18,808	-	-	Direct
May 8, 2025	DXCM DEXCOM INC	Award(A)	1,161	-	-	Direct
May 8, 2025	DXCM DEXCOM INC	Award(A)	5,074	-	-	Direct
Mar 6, 2025	DXCM DEXCOM INC	Award(A)	5,720	-	-	Direct
Mar 5, 2025	JAZZ Jazz Pharmaceuticals plc	Disposition(D)	5,704	$138.95	$792,571	Direct
Feb 27, 2025	JAZZ Jazz Pharmaceuticals plc	Award(A)	11,555	-	-	Direct
Feb 27, 2025	JAZZ Jazz Pharmaceuticals plc	Award(A)	23,111	-	-	Direct
Jan 17, 2025	JAZZ Jazz Pharmaceuticals plc	Tax Payment(F)	3,300	$122.62	$404,646	Direct
Jan 17, 2025	JAZZ Jazz Pharmaceuticals plc	Award(A)	7,741	-	$0	Direct
Dec 5, 2024	JAZZ Jazz Pharmaceuticals plc	Tax Payment(F)	80	$123.45	$9,876	Direct

1-21 of 21 transactions

About GALA RENEE D

GALA RENEE D (SEC CIK 0001607737) files insider reports with the SEC as President & CEO of Jazz Pharmaceuticals plc (JAZZ) and Director of DEXCOM INC (DXCM).

Signal8 holds 18 ownership filings by GALA RENEE D (1 Form 3, 17 Form 4), filed between Dec 9, 2024 and Oct 7, 2026. Those filings report 21 transactions, from Dec 5, 2024 to Oct 6, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on GALA RENEE D's filings is in DUBLIN 4.

Recent filings by GALA RENEE D

Oct 6, 2026: Open-market sale of JAZZ shares (Form 4, code S).
Sep 8, 2026: Open-market sale of JAZZ shares (Form 4, code S).
Sep 8, 2026: Tax withholding of JAZZ shares (Form 4, code F).
Jun 30, 2026: Tax withholding of JAZZ shares (Form 4, code F).
Jun 3, 2026: Gift of JAZZ shares (Form 4, code G).

Other insiders filing for Jazz Pharmaceuticals plc (JAZZ)

COZADD BRUCE C, Director
Patil Neena M, EVP & Chief Legal Officer
Henderson Mary Elizabeth, SVP, Technical Operations
Smith Mark Douglas, Director
RIEDEL NORBERT G, Director
LOVE TED W, Director

How to read Form 4 transaction codes